226 related articles for article (PubMed ID: 33007583)
1. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
[TBL] [Abstract][Full Text] [Related]
2. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin to guide antibiotic decision making.
Branche A; Neeser O; Mueller B; Schuetz P
Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
Covington EW; Roberts MZ; Dong J
Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
[TBL] [Abstract][Full Text] [Related]
6. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D
PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
8. Serum Procalcitonin as A Diagnostic and Prognostic Marker for Bacterial Community - Acquired Pneumonia.
El Maghraby HM; Ismail NA; Mohammed HA
Egypt J Immunol; 2020 Jan; 27(1):37-44. PubMed ID: 33180386
[TBL] [Abstract][Full Text] [Related]
9. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
[TBL] [Abstract][Full Text] [Related]
11. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.
Niederman MS
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S127-32. PubMed ID: 18986278
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis.
Kamat IS; Ramachandran V; Eswaran H; Guffey D; Musher DM
Clin Infect Dis; 2020 Jan; 70(3):538-542. PubMed ID: 31241140
[TBL] [Abstract][Full Text] [Related]
13. Impact of an antimicrobial stewardship program on outcomes in patients with community-acquired pneumonia admitted to a tertiary community hospital.
Gordon K; Stevens R; Westley B; Bulkow L
Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S42-S50. PubMed ID: 29802178
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; van der Reijden TJK; Delfos NM; Leyten EMS; Koster T; Ablij HC; van 't Wout JJW; van Dissel JT
BMC Infect Dis; 2019 Feb; 19(1):161. PubMed ID: 30764769
[TBL] [Abstract][Full Text] [Related]
15. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
17. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia.
Beye F; Vigneron C; Dargent A; Prin S; Andreu P; Large A; Quenot JP; Bador J; Bruyere R; Charles PE
J Crit Care; 2019 Oct; 53():125-131. PubMed ID: 31228763
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program.
Fugit RV; McCoury JB; Bessesen MT
Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S49-S54. PubMed ID: 36371732
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
[TBL] [Abstract][Full Text] [Related]
20. Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit.
Gilbert DN
Infect Dis Clin North Am; 2017 Sep; 31(3):435-453. PubMed ID: 28779830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
